SE7613588L - Forfarande for framstellning av 3,4-dihydro-kinazolinderivat - Google Patents

Forfarande for framstellning av 3,4-dihydro-kinazolinderivat

Info

Publication number
SE7613588L
SE7613588L SE7613588A SE7613588A SE7613588L SE 7613588 L SE7613588 L SE 7613588L SE 7613588 A SE7613588 A SE 7613588A SE 7613588 A SE7613588 A SE 7613588A SE 7613588 L SE7613588 L SE 7613588L
Authority
SE
Sweden
Prior art keywords
dihydro
procedure
preparation
derivatives
chinazoline derivatives
Prior art date
Application number
SE7613588A
Other languages
English (en)
Swedish (sv)
Inventor
G Doria
C Romeo
P Giraldi
F Lauria
M L Corno
P Sberze
M Tibolla
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of SE7613588L publication Critical patent/SE7613588L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/93—Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7613588A 1975-12-05 1976-12-03 Forfarande for framstellning av 3,4-dihydro-kinazolinderivat SE7613588L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT29998/75A IT1050750B (it) 1975-12-05 1975-12-05 Derivati della 3.4 di idro chinazolina

Publications (1)

Publication Number Publication Date
SE7613588L true SE7613588L (sv) 1977-06-06

Family

ID=11228830

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7613588A SE7613588L (sv) 1975-12-05 1976-12-03 Forfarande for framstellning av 3,4-dihydro-kinazolinderivat

Country Status (22)

Country Link
US (1) US4251531A (fr)
JP (1) JPS5271485A (fr)
AT (1) AT355029B (fr)
AU (1) AU505660B2 (fr)
BE (1) BE848696A (fr)
CA (1) CA1084051A (fr)
CH (2) CH626073A5 (fr)
CS (1) CS194786B2 (fr)
DE (1) DE2654215A1 (fr)
DK (1) DK147855C (fr)
FI (1) FI64359C (fr)
FR (1) FR2333511A1 (fr)
GB (1) GB1523081A (fr)
HU (1) HU177817B (fr)
IL (1) IL50849A (fr)
IT (1) IT1050750B (fr)
NL (1) NL7613450A (fr)
NO (1) NO146095C (fr)
NZ (1) NZ182778A (fr)
SE (1) SE7613588L (fr)
SU (1) SU786894A3 (fr)
ZA (1) ZA766745B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419357A (en) 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
ES8501397A1 (es) * 1982-08-05 1984-11-16 Erba Farmitalia "procedimiento para preparar derivados de quinazolina"
US4666913A (en) * 1985-11-22 1987-05-19 William H. Rorer, Inc. Hydroxy and aminothiazolyl-benzodiazinone compounds, cardiotonic compositions including the same, and their uses
GB8827988D0 (en) * 1988-11-30 1989-01-05 Smith Kline French Lab Chemical compounds
US5430148A (en) * 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
ES2276519T3 (es) * 1998-05-22 2007-06-16 Abbott Laboratories Un medicamento antiangiogenico para el tratamiento del cancer, de la artritis y de la retinopatia.
US6632961B1 (en) * 1998-05-22 2003-10-14 Abbott Laboratories Antiangiogenic drug to treat cancer, arthritis and retinopathy
CO5170498A1 (es) * 1999-05-28 2002-06-27 Abbott Lab Biaril sulfonamidas son utiles como inhibidores de proliferacion celular
EP1389103A4 (fr) * 2001-04-23 2005-09-14 Univ Virginia Synthese et evaluation de nouvelles substances mimetiques de phthalimide comme agents antiangiogenese
CN100518740C (zh) * 2003-06-06 2009-07-29 阿里克斯股份公司 杂环化合物作为scce抑制剂的制药用途
US7872052B2 (en) * 2003-06-06 2011-01-18 Arexis Ab Use of heterocyclic compounds as SCCE inhibitors
JP5193866B2 (ja) * 2006-08-08 2013-05-08 あすか製薬株式会社 キナゾリン誘導体
DK2118074T3 (en) 2007-02-01 2014-03-10 Resverlogix Corp Compounds for the prevention and treatment of cardiovascular diseases
KR101709492B1 (ko) 2009-03-18 2017-02-23 리스버로직스 코퍼레이션 신규한 소염제
US9757368B2 (en) 2009-04-22 2017-09-12 Resverlogix Corp. Anti-inflammatory agents
US10111885B2 (en) 2015-03-13 2018-10-30 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases
GB201510254D0 (en) * 2015-06-12 2015-07-29 Syngenta Participations Ag Improvements in or relating to organic compounds
CA3105174A1 (fr) * 2018-06-27 2020-01-02 Reborna Biosciences, Inc. Agent prophylactique ou therapeutique pour amyotrophie spinale

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3696102A (en) * 1970-03-09 1972-10-03 Pfizer & Co C Process for the synthesis of substituted quinazolin-4-ones
GB1301319A (fr) 1970-07-13 1972-12-29

Also Published As

Publication number Publication date
AT355029B (de) 1980-02-11
IL50849A (en) 1980-11-30
CH626075A5 (fr) 1981-10-30
NL7613450A (nl) 1977-06-07
NO764135L (fr) 1977-06-07
IT1050750B (it) 1981-03-20
JPS5543464B2 (fr) 1980-11-06
NO146095C (no) 1982-08-11
NO146095B (no) 1982-04-19
US4251531A (en) 1981-02-17
FR2333511B1 (fr) 1979-03-02
JPS5271485A (en) 1977-06-14
DE2654215A1 (de) 1977-06-16
DK147855C (da) 1985-06-10
ZA766745B (en) 1977-10-26
AU1947276A (en) 1978-05-18
CH626073A5 (fr) 1981-10-30
FI64359B (fi) 1983-07-29
ATA894376A (de) 1979-07-15
CS194786B2 (en) 1979-12-31
FR2333511A1 (fr) 1977-07-01
DK546776A (da) 1977-06-06
CA1084051A (fr) 1980-08-19
DK147855B (da) 1984-12-24
NZ182778A (en) 1978-07-28
HU177817B (en) 1981-12-28
BE848696A (fr) 1977-03-16
AU505660B2 (en) 1979-11-29
FI64359C (fi) 1983-11-10
SU786894A3 (ru) 1980-12-07
IL50849A0 (en) 1977-01-31
GB1523081A (en) 1978-08-31
FI763391A7 (fr) 1977-06-06

Similar Documents

Publication Publication Date Title
IT1075017B (it) Procedimento per il trattamento di estratti antocianinici
NO155885C (no) Analogifremgangsmaate for fremstilling av tiazolderivater med anti-ulcus-egenskaper.
RO68460A (fr) Procede pour la preparation des derives d'azetidinone
IT1057250B (it) Derivati del 6..7 benzomorfano e procedimento per la loro preparazione
SE7606225L (sv) Forfarande for framstellning av heteroarylforeningar
SE7603791L (sv) Forfarande for framstellning av 17 alfa-ester-21-halogenpregnaner
NL7613450A (nl) 3.4-dihydrochinazolinederivaten en werkwijzen ter bereiding ervan.
MX3743E (es) Procedimiento para la preparacion de derivados 3,4-dihidro-2 (lh)-quinazolinona
PT66089B (en) Process for preparing 1,2-benzisothiazolin-3-ona with anti-thrombotic effect application of same for the preparationof pharmaceutical compositions with anti-thrombic effect and application of these pharmaceutical compositions for the treatment of thrombosis
SE433353B (sv) Analogiforfarande for framstellning av pyrido/1,2-a/pyrimidiner med antiflogistisk och koagulationshemmande verkan
IT8021795A0 (it) Derivati del 5h-furanone-2 e del3h-diidrofuranone-2,loro procedimento di preparazione e loro applicazione terapeutica.
AR204390A1 (es) Procedimiento de preparacion de derivados de imidazolidinonas y perhidropirimidinonas n,n' bisustituidas
SE435290B (sv) Forfarande for framstellning av gamma-kristallin form av natrium-7-(d-alfa-formyloxi-alfa-fenylacetamido)-(2-metyl-1h-tetrazol-5-yltiometyl)-3-cefem-4-karboxylat
SE7813277L (sv) Komposition och sett for behandling av hypertension
BG43187A3 (bg) Метод за получаване на ауронови производни
SE407937B (sv) Forfarande for framstellning av 1,3,4-substituerade 2-pyrrolidoner med terapentiska egenskaper
BE846956A (fr) Derives de 1-carbamoyl-k-fluorouracile et leur utilisation comme agents antineoplasiques,
AR215851A1 (es) Procedimiento para la preparacion de 12,13-desepoxi-12,13-dehidrorosaramicina y derivados de la misma
SE7808138L (sv) Pyranokromonderivat och terapeutisk komposition innehallande detsamma for behandling av allergiska sjukdomar
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
MX144463A (es) Composicion pigmentaria de 2,9-dicloroquinacridona
NO142444C (no) Fremgangsmaate for fremstilling av foretrede melamin-formaldehydharpikser i vandig opploesning
SE7713587L (sv) Forfarande for framstellning av oxazolidindionderivat av vinkaalkaloider
SE7611952L (sv) Forfarande for framstellning av aroyl-fenylinden- och aroyl-fenylnaftalenderivat anvendbara sasom antifertilitetsmedel
SE423814B (sv) Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7613588-8